This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 2.30% and 0.12%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy?
by Zacks Equity Research
NUS' subsidiary has sold its Mavely affiliate marketing platform to Later for nearly $250 million, boosting innovation and resources.
Helen of Troy Set to Release Q3 Earnings: Should You Expect a Beat?
by Zacks Equity Research
HELE's Q3 results are likely to reflect challenges stemming from a tough macroeconomic landscape and high SG&A costs, while Leadership Brands have been aiding.
Ahead of Helen of Troy (HELE) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Helen of Troy (HELE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended November 2024.
Here's Why Helen of Troy is Well Positioned for Growth in 2025
by Zacks Equity Research
HELE's strategic initiatives are driving innovation, efficiency and long-term growth, positioning the company for sustained success across its brands.
HELE vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
Should Value Investors Buy Helen of Troy (HELE) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Lamb Weston (LW) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Lamb Weston (LW) delivered earnings and revenue surprises of -35.29% and 4.30%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
HELE Broadens Beauty Offering With Olive & June Buyout: What's Next?
by Zacks Equity Research
Helen of Troy's acquisition of Olive & June is a strategic move that broadens its beauty portfolio and positions the company for future growth.
Is HELE Stock Still Worth Buying After a 37% Surge in 3 Months?
by Zacks Equity Research
Helen of Troy is focused on executing long-term growth strategies, reshaping its portfolio and skillfully managing challenges in a tough macroeconomic environment.
HELE's Olive & June Buyout to Boost Its Presence in the Beauty Space
by Zacks Equity Research
Helen of Troy plans to acquire Olive & June, a leading nail care brand, aiming to expand its presence in the beauty industry and diversify product offerings.
Zacks Industry Outlook Highlights Coty, Helen of Troy, European Wax Center and Nu Skin
by Zacks Equity Research
Coty, Helen of Troy, European Wax Center and Nu Skin are part of the Zacks Industry Outlook article.
4 Cosmetics Stocks Worth Watching Despite Industry Challenges
by Ansuiya Mohta
The Zacks Cosmetics industry is navigating a tough shopping environment. Nevertheless, COTY, Helen of Troy, European Wax Center and Nu Skin are leveraging innovations.
Should SharkNinja Stock be Part of Your Portfolio Ahead of Q3 Earnings?
by Ankita Gupta
Does SN's innovative and differentiated product offerings stand out as a top investment choice before third-quarter earnings?
Company News for Oct 10, 2024
by Zacks Equity Research
Companies in The News Are: HELE,BAALTM,RIO,MSFT
Helen of Troy Q2 Earnings Top, Beauty & Wellness Sales Decline Y/Y
by Zacks Equity Research
Helen of Troy's Q2 earnings reflect the impact of soft sales, stemming from a decline in Beauty & Wellness sales. Margins also contract year over year.
Helen of Troy (HELE) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Helen of Troy (HELE) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Helen of Troy (HELE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 12.04% and 3.71%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
Markets Bounce Back Behind Mag-7 Momentum
by Mark Vickery
The tech-heavy Nasdaq led the way higher - +259 points, +1.45% - followed by the S&P +0.97% and the blue-chip Dow +0.30%.
Helen of Troy Q2 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
HELE's Q2 performance is likely to reflect the impacts of weak consumer spending amid inflationary pressures.
Gear Up for Helen of Troy (HELE) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Helen of Troy (HELE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended August 2024.
Helen of Troy Stock Falls 40% in Three Months: What's Next for HELE?
by Zacks Equity Research
HELE is battling operational challenges, rising costs and macroeconomic uncertainty, leading to a weaker fiscal 2025 outlook.
SharkNinja's Stock Surges 103% in YTD: Should You Jump Onboard?
by Ankita Gupta
Does SN's innovative and differentiated product offerings stand out as a top investment choice?
Limoneira (LMNR) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 31.25% and 0.85%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
HELE's New $500 Million Buyback Program: A Signal to Hold or Fold?
by Zacks Equity Research
Helen of Troy unveils a $500-million share repurchase program, signaling a powerful commitment to enhancing shareholders' value.